Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Label-Free Quantification of Bilirubin Using a Refractive Index-Insensitive Nanolaminate SERS Substrate.

Biosensors·2026

Same author

PKGPT: Expert-Orchestrated Recursive LLM Agent for Automated NONMEM PopPK Modeling with Human Benchmarking.

Pharmaceutics·2026

Same author

Molecular role of developmentally regulated GTP-binding protein 1 in coordinating osteoclast and osteoblast differentiation during bone remodeling.

Molecules and cells·2026

Same author

Flexible Bayesian Inference for Identifying Significantly Correlated Multiple Pathway Sets.

Statistics in medicine·2026

Same author

CaMKIV negatively regulates osteoblast differentiation by modulating c-Fos and NFATc1 signaling: an in vitro and in vivo mechanistic study.

BMB reports·2026

Same author

MKRN1 Regulates RANKL-Induced Differentiation Via Akt and AMPK Pathways.

Journal of cellular physiology·2025

Same journal

Association between intestinal functional disorders and anal fistula: evidence from a retrospective case-control study.

PeerJ·2026

Same journal

Automated recognition of Meso-Cenozoic foraminifera from Senegalese sedimentary deposits using convolutional neural networks.

PeerJ·2026

Same journal

Genome-wide analysis of <i>HSP70</i> gene superfamily in kelp (<i>Saccharina japonica</i>): identification, characterization, and heat stress-responsive expression profiles.

PeerJ·2026

Same journal

Morphological and molecular evidence of the Antarctic sleeper shark <i>Somniosus antarcticus</i> (Somniosidae) in northern Chile.

PeerJ·2026

Same journal

Stroboscopic balance training enhances dynamic stability and postural control in collegiate badminton players: a randomized controlled trial.

PeerJ·2026

Same journal

Frequent exposure to biologics is associated with small intestinal bacterial overgrowth in patients with Crohn's disease: a retrospective case-control study.

PeerJ·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 12, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

PKPy: a Python-based framework for automated population pharmacokinetic analysis.

Hyunseung Kong¹, Inyoung Kim², Byoung-Tak Zhang^1,3

¹Interdiciplinary Program Bioinformatics, Seoul National University, Seoul, Republic of South Korea.

|November 3, 2025

Summary

This summary is machine-generated.

PKPy, an open-source Python framework, automates population pharmacokinetic analysis, offering user-friendly parameter estimation and robust diagnostics. It demonstrates high accuracy and computational efficiency compared to existing tools.

Keywords:

Pharmacometrics Population pharmacokinetics Python

More Related Videos

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

Related Experiment Videos

Last Updated: Jan 12, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

Area of Science:

Pharmacokinetics and Pharmacometrics
Computational Biology
Drug Development

Background:

Population pharmacokinetic (PopPK) analysis is crucial for understanding drug disposition in diverse patient populations.
Existing tools often require manual parameter initialization, posing a barrier to accessibility and potentially impacting analytical rigor.
Automating PopPK workflows can enhance efficiency and reproducibility in drug development.

Purpose of the Study:

To introduce PKPy, an open-source Python framework for automating population pharmacokinetic analysis.
To provide a user-friendly yet analytically rigorous platform for parameter estimation, covariate analysis, and diagnostics.
To evaluate PKPy's performance and compare its efficiency against established software.

Main Methods:

Developed PKPy implementing one- and two-compartment models with first-order absorption.
Evaluated performance using simulation studies with varying sample sizes (20-100 subjects).
Compared PKPy's installation and analysis times against Saemix+PKNCA and nlmixr2.

Main Results:

PKPy demonstrated robust parameter estimation (bias <3%, recovery >98% for one-compartment models).
Accurate identification of covariate relationships (100%) and high model fit (R² ≥ 0.97).
PKPy showed significant computational advantages, with faster installation and analysis times.

Conclusions:

PKPy offers an accessible, transparent, and efficient platform for pharmacokinetic analysis.
The framework successfully automates complex workflows while maintaining scientific rigor.
PKPy has the potential to lower barriers to entry in pharmacometric analysis.